Literature DB >> 12378196

What factors influence the age at diagnosis of hemophilia? Results of the French hemophilia cohort.

Hervé Chambost1, Valérie Gaboulaud, Brigitte Coatmélec, Anne Rafowicz, P Schneider, Thierry Calvez.   

Abstract

OBJECTIVE: The diagnosis of hemophilia was reported as delayed in historic studies. We therefore investigated this issue to provide current epidemiologic data in a large series of patients. STUDY
DESIGN: The French cohort provided the opportunity to investigate the age at diagnosis and the circumstances of diagnosis in 599 individuals with hemophilia born between 1980 and 1994. The type and the severity of hemophilia, the family history, and the period of birth were analyzed as potential modifying factors.
RESULTS: The median age at diagnosis was 7.7 months, with significant differences among subgroups: 5.8 months in severe hemophilia, 9.0 months in moderate forms, 28.6 months in mild forms, 0.4 months in the case of hemophilic brothers, and 10.1 months in de novo hemophilia, which accounted for 55.3% of cases. In severe forms we observed a trend for earlier diagnosis throughout 3 consecutive periods from 1980 to 1994. Of bleeding episode, testing due to family history, or routine testing, bleeding was the main circumstance of diagnosis (59.9%).
CONCLUSIONS: Diagnosis was made earlier than in historic series, but it remained somewhat delayed. Early diagnosis will require efforts in the fields of genetic counseling and specific diagnosis of early bleeding, even without family history, because of the high incidence of de novo hemophilia.

Entities:  

Mesh:

Year:  2002        PMID: 12378196     DOI: 10.1067/mpd.2002.128115

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  9 in total

1.  FranceCoag: a 22-year prospective follow-up of the national French cohort of patients with inherited bleeding disorders.

Authors:  Alexandra Doncarli; Virginie Demiguel; Irina Guseva Canu; Véronique Goulet; Sophie Bayart; Thierry Calvez; Sabine Castet; Vincent Dalibard; Yohan Demay; Birgit Frotscher; Jenny Goudemand; Thierry Lambert; Vanessa Milien; Caroline Oudot; Thomas Sannié; Hervé Chambost
Journal:  Eur J Epidemiol       Date:  2018-12-05       Impact factor: 8.082

Review 2.  Neonatal coagulation problems.

Authors:  E A Chalmers
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-11       Impact factor: 5.747

Review 3.  Diagnosis and care of patients with mild haemophilia: practical recommendations for clinical management.

Authors:  Gary Benson; Günter Auerswald; Gerry Dolan; Anne Duffy; Cedric Hermans; Rolf Ljung; Massimo Morfini; Silva Zupančić Šalek
Journal:  Blood Transfus       Date:  2017-11-14       Impact factor: 3.443

4.  Challenges in the Diagnosis and Management of Non-Severe Hemophilia.

Authors:  Estera Boeriu; Teodora Smaranda Arghirescu; Margit Serban; Jenel Marian Patrascu; Eugen Boia; Cristian Jinca; Wolfgang Schramm; Adina Traila; Cristina Emilia Ursu
Journal:  J Clin Med       Date:  2022-06-09       Impact factor: 4.964

5.  Neonatal Gene Therapy for Hemophilia B by a Novel Adenovirus Vector Showing Reduced Leaky Expression of Viral Genes.

Authors:  Shunsuke Iizuka; Fuminori Sakurai; Masashi Tachibana; Kazuo Ohashi; Hiroyuki Mizuguchi
Journal:  Mol Ther Methods Clin Dev       Date:  2017-07-08       Impact factor: 6.698

Review 6.  Hemophilia Care in the Pediatric Age.

Authors:  Marta Bertamino; Francesca Riccardi; Laura Banov; Johanna Svahn; Angelo Claudio Molinari
Journal:  J Clin Med       Date:  2017-05-19       Impact factor: 4.241

7.  Mode of delivery in hemophilia: vaginal delivery and Cesarean section carry similar risks for intracranial hemorrhages and other major bleeds.

Authors:  Nadine G Andersson; Elizabeth A Chalmers; Gili Kenet; Rolf Ljung; Anne Mäkipernaa; Hervé Chambost
Journal:  Haematologica       Date:  2019-02-21       Impact factor: 9.941

Review 8.  Hemostatic Challenges in Neonates.

Authors:  Patricia Davenport; Martha Sola-Visner
Journal:  Front Pediatr       Date:  2021-03-02       Impact factor: 3.418

9.  Haemophilia in France: Modelisation of the Clinical Pathway for Patients.

Authors:  Karen Beny; Benjamin du Sartz de Vigneulles; Florence Carrouel; Denis Bourgeois; Valérie Gay; Claude Negrier; Claude Dussart
Journal:  Int J Environ Res Public Health       Date:  2022-01-06       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.